ISPOR Announces New Editor-in-Chief for Value in Health, Nancy J. Devlin, PhD

Published Dec 18, 2023

Lawrenceville, NJ, USA—December 18, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the appointment of Nancy J. Devlin, PhD, University of Melbourne, Australia as an editor-in-chief for Value in Health.

Dr Devlin is a professor of health economics in the Melbourne School of Population and Global Health, University of Melbourne; chair of the board of the EuroQol Research Foundation (Rotterdam, The Netherlands); and a senior research fellow at the Office of Health Economics (London, UK). She has also held several leadership roles at ISPOR, including serving as co-chairs of several Good Practices Task Forces, the board of directors (2015-2017), and as president (2019-2020).

“As the flagship journal of ISPOR and arguably the leading journal in HEOR, Value in Health has a pivotal role in disseminating evidence and promoting good science in health economics and outcomes research,” Dr Devlin said. “It is a great honor to have the opportunity to serve as editor-in-chief for Value in Health and to work in partnership with C. Daniel Mullins, PhD and the editorial board to sustain and further strengthen Value in Health’s quality and impact.”

Dr Devlin has been deeply engaged with innovative methods research in HEOR throughout the span of her 35+-year career as a health economist. Her research focuses on 2 principal areas: how to use cost effectiveness evidence to judge value for money in healthcare; and the measurement and valuation of patient-reported outcomes.

“ISPOR and Value in Health are excited to welcome Nancy to this role,” stated ISPOR CEO and Executive Director Rob Abbott. “Her level of experience and understanding of international healthcare systems and policies will be a tremendous asset to the journal and to the organization.”

Dr Devlin will officially assume her role on January 1, 2024 and will replace Michael F. Drummond, MCom, DPhil, who will retire in April 2024 after leaving an indelible mark on the journal during his 14 years in the role.

###

 

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

ABOUT VALUE IN HEALTH
Value in Health
(ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2022 impact factor score is 4.5 and its 5-year impact factor score is 6.2. Value in Health is ranked 8th of 87 journals in health policy and services, 21st of 105 journals in healthcare sciences and services, and 69th of 380 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Website
  | Twitter (@isporjournals)

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×